Sana Biotechnology (SANA) Reiterated at Market Outperform by Citizens on Mayo Partnership

April 15, 2026 5:47 AM

Citizens analyst Reni Benjamin reiterated a Market Outperform rating and $8.00 price target on Sana Biotechnology (NASDAQ: SANA).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found